Hospital Pharmacy Europe - Endocrine disorders,

Click here

Tuesday 21 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Endocrine disorders

Magazine	Sponsored content
News	Video

Fri 8 Feb

New Forum and recommendations for diabetes injection technique launched in Ireland
The Forum for Injection Technique (FIT) announce the launch of FIT in Ireland, and the First Irish Injection Technique...

Wed 14 Nov
2012

Boehringer Ingelheim supports ‘Life for a Child’ programme
Today (14th Nov) sees the culmination of week-long activities at Boehringer Ingelheim aiming to raise awareness of the global...

Thu 8 Nov
2012

Signifor® recommended by FDA advisory committee
The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously...

Mon 29 Oct
2012

European approval granted for Trajenta®
Boehringer Ingelheim and Eli Lilly and Company have announced that the European Commission has approved an expanded therapeutic...

Thu 4 Oct
2012

Insulin degludec two-year study
New data presented today at the Annual Meeting of the European Association for the Study of Diabetes (EASD) show that patients...

Wed 3 Oct
2012

Health outcomes data for basal insulin analogue
Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim today announced patient-reported health outcomes data from a Phase II...

Wed 3 Oct
2012

Patient study demonstrates real-world effectiveness of Galvus®
Novartis announced today new data showing that a significantly higher proportion of type 2 diabetes patients responded to...

Tue 25 Sep
2012

CHMP recommends indication for the use of Trajenta®
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a Positive Opinion from the European...

Fri 21 Sep
2012

Two CHMP positive opinions for diabetes treatments
Novartis announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued...

Thu 20 Sep
2012

Global recommendations on ensuring safety of diabetes injections
WISE (Workshop on Injection Safety in Endocrinology) has published new global recommendations on ensuring the safety of...

Tue 24 Jul
2012

Albireo AB liver drug receives positive opinion
EMA Committee for Orphan Medicinal Products issued positive opinion for hepatology candidate A4250

Mon 11 Jun
2012

Linagliptin combinations 'clinically meaningful'
Positive Phase III data for linagliptin combinations presented at the ADA conference

Wed 25 Apr
2012

Signifor® approved by EC for Cushing's disease
The drug has been approved for adult patients for whom surgery is not an option or has failed

Mon 23 Apr
2012

EMA backs authorisation new diabetes drug
Granting of marketing authorisation supported for dapagliflozin, to treat type 2 diabetes mellitus

Thu 19 Apr
2012

Oral medication value for type 2 diabetes questioned
Insulin with and without metformin for type 2 diabetes compared in systematic review of clinical trials

Mon 2 Apr
2012

Peginasetide antianaemic approved by FDA
Approval comes after EMA acceptance of application for marketing authorisation

Thu 29 Mar
2012

Pasireotide shows potential for Cushing's disease
Positive Phase 3 results published in the New England Journal of Medicine

Thu 8 Mar
2012

Phase III first for Cushing's disease drug
Findings published in the NEJM are first Phase III trial to show efficacy in Cushing's disease

Web design, hosting and programming by ModeZero